Ana León Rodríguez is addressing the issue of microglial priming in the brain, caused by events like traumatic brain injuries, leading to increased neurotoxicity and the risk of neurological diseases. Her solution involves developing a vaccine using the immunomodulatory properties of Mycobacterium vaccae, a soil-derived bacteria, to attenuate microglial priming and prevent the consequences for millions of people worldwide, offering a potential breakthrough in the prevention of diseases such as Alzheimer’s and Schizophrenia.
Login or Register
You need to be logged in to use this feature.
Falling Walls Lab
Breaking the Wall of Microglial Priming
Ana León Rodríguez
Ana León Rodríguez is a PhD Fellow in Neuroinflammation at the University of Málaga. Her research focuses on microglial cells, the immune cells of the central nervous system, which act as police officers protecting it. Her main goal is to characterise microglial priming and find strategies to modulate it. She studied biology at the University of Málaga and Salford University. Since 2018, she has been working in neuroscience funded by different research fellowships (Ministry of Spain, University of Málaga, Fulbright Spain). In addition, she loves science communication and is involved in a wide range of activities that enable her to show her passion and work to everyone.